According to a new market research report "artificial insulin market - drugs (biological products, biosimilars), type (short-acting, long-acting, premixed), brand, drug delivery equipment (pen, pen needle, syringe) application (Type 1 diabetes, type 2 diabetes) - predicted by 2020 "Global artificial insulin market is expected to reach $ 3.913 billion in 2020, according to 8.1% from 2015 annual compound annual growth rate increased to 2020, the study of the global The market is forecast by 2015 to 2020.
On the basis of the product, the global artificial insulin market is divided into two parts, namely, drugs and delivery devices. The type of drug (available, effective, long-acting, short-acting and premixed) and drug brands on the artificial insulin drug market are further divided. In addition, the artificial insulin delivery device market is divided into insulin pens (reusable and disposable), stylus (standard and safe), and conventional syringes. In addition, the Global Artificial Insulin Market Category application is integrated into the application of type I diabetes and based on the application of type 2 diabetes
Such as growing diabetics, increasing human exposure to major risk factors leading to diabetes, ascending to artificial insulin analogues, advances in the field of artificial insulin delivery devices, and favorable medical market demand factors driving the growth of the artificial insulin market during the forecast period Inside. However, strict regulatory requirements for product approval have inhibited the growth of this market.